Cases 41 - 50 of 457
Aragon Pharmaceuticals, Inc. et al v. Lupin Limited et al
as 1:2022cv00637
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc. and Sloan Kettering Institute for Cancer Research
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. LUPIN LIMITED et al
as 2:2022cv02825
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Defendant:
LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JAZZ PHARMACEUTICALS IRELAND LIMITED v. LUPIN LTD. et al
as 2:2022cv02773
Plaintiff:
JAZZ PHARMACEUTICALS IRELAND LIMITED
Defendant:
LUPIN LTD., LUPIN INC. and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exeltis USA, Inc. et al v. Lupin Ltd. et al
as 1:2022cv00434
Counter Defendant:
Exeltis USA, Inc., Laboratorios Leon Farma, S.A., Chemo Iberica, S.A. and others
Counter Claimant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Health Care Service Corporation, a Mutual Legal Reserve Company v. Jazz Pharmaceuticals, Inc. et al
as 3:2022cv00993
Plaintiff:
Health Care Service Corporation, a Mutual Legal Reserve Company and Health Care Service Corporation
Defendant:
Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals Public Limited Company and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
BAUSCH & LOMB, INC. et al v. LUPIN LTD.
as 3:2022cv00534
Plaintiff:
BAUSCH & LOMB, INC., BAUSCH & LOMB IRELAND LIMITED and EYE THERAPIES, LLC
Defendant:
LUPIN LTD., LUPIN ATLANTIS HOLDINGS SA, LUPIN INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
H. Lundbeck A/S v. Lupin Ltd.
as 22-1246
Plaintiff / Appellee:
H. LUNDBECK A/S, TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC. and others
Defendant:
LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and SANDOZ AG
Defendant / Appellant:
MACLEODS PHARMACEUTICALS LTD., MACLEODS PHARMA USA, INC., ALEMBIC PHARMACEUTICALS LIMITED and others
TARO PHARMACEUTICALS U.S.A., INC. et al v. LUPIN LIMITED et al
as 1:2021cv20320
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN ATLANTIS HOLDING SA
Cause Of Action: 35 U.S.C. § 271
TARO PHARMACEUTICALS U.S.A., INC. et al v. LUPIN LIMITED et al
as 2:2021cv20320
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN ATLANTIS HOLDING SA
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
